\-\ Texto\\:\\ \ \(0\)\
\-\ bilateral\\ hip\\ pain\ \(11\)\
\-\ patient\\ is\\ continued\\ on\\ medical\\ management\\ and\\ will\\ likely\\ need\\ hip\\ replacements\\ relatively\\ early\ \(0\)\
\-\ subchondral\\ sclerosis\\ and\\ collapse\\ with\\ cyst\\ formation\\ in\\ both\\ femoral\\ heads\\.\ \(0\)\
\-\ contour\\ abnormality\\ in\\ both\\ femoral\\ heads\\ \\(flattening\\)\ \(1\)\
\-\ avn\ \(0\)\
\-\ avn\ \(0\)\
\-\ active\\ duty\\ man\\ with\\ hip\\ pain\\.\ \(0\)\
\-\ evaluation\\ in\\ total\\ joint\\ clinic\ \(0\)\
\-\ report\\ of\\ avn\\ in\\ both\\ hips\ \(0\)\
\-\ avn\\ in\\ \\ a\\ young\\,\\ active\\ duty\\ male\\ is\\ often\\ associated\\ with\\ steroid\\ use\\.\\ \\ other\\ potential\\ causes\\ in\\ this\\ patient\\ include\\ trauma\\,\\ infection\\ and\\ caisson\\ dz\\.\\ \\ chronic\\/inflamatory\\ causes\\ such\\ as\\ sickle\\ cell\\ disease\\,\\ lupus\\,\\ gaucher\\'s\\ dz\\ or\\ radiation\\ therapy\\ are\\ much\\ less\\ likely\\ in\\ a\\ service\\ member\\ on\\ active\\ duty\\.\\ \ \(0\)\
\-\ although\\ cases\\ as\\ advanced\\ as\\ this\\ are\\ clearly\\ visible\\ on\\ plain\\ film\\,\\ avn\\ is\\ best\\ evaluated\\ on\\ mr\\ imaging\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ avn\\:\\ 0\\.21584850900000213\ \(0\)\
\-\ duty\\:\\ 0\\.09835609405757884\ \(0\)\
\-\ dz\\:\\ 0\\.0919201333309553\ \(0\)\
\-\ heads\\:\\ 0\\.07614606270941342\ \(0\)\
\-\ hip\\:\\ 0\\.07508541997304688\ \(0\)\
\-\ active\\:\\ 0\\.07196820968481354\ \(0\)\
\-\ chronic\\/inflamatory\\:\\ 0\\.06481998841151837\ \(0\)\
\-\ member\\:\\ 0\\.05164528643190031\ \(0\)\
\-\ replacements\\:\\ 0\\.050511825550817534\ \(0\)\
\-\ caisson\\:\\ 0\\.04952997707563722\ \(0\)\
\-\ causes\\:\\ 0\\.04892030437955605\ \(0\)\
\-\ both\\:\\ 0\\.04813676450042915\ \(0\)\
\-\ femoral\\:\\ 0\\.04780879436240889\ \(0\)\
\-\ gaucher\\:\\ 0\\.044433306630343505\ \(0\)\
\-\ hips\\:\\ 0\\.036995064632707624\ \(0\)\
\-\ lupus\\:\\ 0\\.036995064632707624\ \(0\)\
\-\ service\\:\\ 0\\.03635527509601917\ \(0\)\
\-\ likely\\:\\ 0\\.03544544067552436\ \(0\)\
\-\ sickle\\:\\ 0\\.034714513689297045\ \(0\)\
\-\ flattening\\:\\ 0\\.03423996573975607\ \(0\)\
\-\ steroid\\:\\ 0\\.03317245096148771\ \(0\)\
\-\ subchondral\\:\\ 0\\.03297636090941299\ \(0\)\
\-\ clearly\\:\\ 0\\.032328513354190444\ \(0\)\
\-\ collapse\\:\\ 0\\.032153435054971924\ \(0\)\
\-\ advanced\\:\\ 0\\.032153435054971924\ \(0\)\
\-\ need\\:\\ 0\\.03133559950269087\ \(0\)\
\-\ contour\\:\\ 0\\.03046095286400435\ \(0\)\
\-\ potential\\:\\ 0\\.030257632780691778\ \(0\)\
\-\ visible\\:\\ 0\\.029741424996329657\ \(0\)\
\-\ much\\:\\ 0\\.029086073673564895\ \(0\)\
\-\ evaluated\\:\\ 0\\.028806460470702844\ \(0\)\
\-\ as\\:\\ 0\\.028512739100605762\ \(0\)\
\-\ report\\:\\ 0\\.028125631155792367\ \(0\)\
\-\ clinic\\:\\ 0\\.028075780516193992\ \(0\)\
\-\ young\\:\\ 0\\.027365942817351\ \(0\)\
\-\ continued\\:\\ 0\\.027056764609678208\ \(0\)\
\-\ total\\:\\ 0\\.027056764609678208\ \(0\)\
\-\ relatively\\:\\ 0\\.026885758270235066\ \(0\)\
\-\ best\\:\\ 0\\.026435019109471863\ \(0\)\
\-\ formation\\:\\ 0\\.02593567200935267\ \(0\)\
\-\ use\\:\\ 0\\.024834111140024283\ \(0\)\
\-\ film\\:\\ 0\\.02413330099440425\ \(0\)\
\-\ management\\:\\ 0\\.023709790025409128\ \(0\)\
\-\ abnormality\\:\\ 0\\.023180573116401117\ \(0\)\
\-\ early\\:\\ 0\\.022979110070900276\ \(0\)\
\-\ sclerosis\\:\\ 0\\.022568494363429007\ \(0\)\
\-\ in\\:\\ 0\\.02168956331604253\ \(0\)\
\-\ on\\:\\ 0\\.021290912128394943\ \(0\)\
\-\ less\\:\\ 0\\.021278970620019724\ \(0\)\
\-\ although\\:\\ 0\\.02122006823953385\ \(0\)\
\-\ cases\\:\\ 0\\.02093243282339068\ \(0\)\
\-\ radiation\\:\\ 0\\.020619494482076003\ \(0\)\
\-\ plain\\:\\ 0\\.02040635082859621\ \(0\)\
\-\ joint\\:\\ 0\\.020319332757662362\ \(0\)\
\-\ often\\:\\ 0\\.020047599621468033\ \(0\)\
\-\ mr\\:\\ 0\\.019964701999606132\ \(0\)\
\-\ will\\:\\ 0\\.019657948664552515\ \(0\)\
\-\ such\\:\\ 0\\.019642152866476855\ \(0\)\
\-\ medical\\:\\ 0\\.019333160294602973\ \(0\)\
\-\ infection\\:\\ 0\\.018264827750535347\ \(0\)\
\-\ evaluation\\:\\ 0\\.018251755851667703\ \(0\)\
\-\ include\\:\\ 0\\.017626128588457992\ \(0\)\
\-\ trauma\\:\\ 0\\.017183888101161244\ \(0\)\
\-\ are\\:\\ 0\\.01713049812543532\ \(0\)\
\-\ cell\\:\\ 0\\.016972358173393282\ \(0\)\
\-\ cyst\\:\\ 0\\.01688508188254487\ \(0\)\
\-\ therapy\\:\\ 0\\.016798829384122155\ \(0\)\
\-\ pain\\:\\ 0\\.01534717893427551\ \(0\)\
\-\ bilateral\\:\\ 0\\.01524865977437091\ \(0\)\
\-\ man\\:\\ 0\\.014859792963897053\ \(0\)\
\-\ associated\\:\\ 0\\.014826930602262514\ \(0\)\
\-\ imaging\\:\\ 0\\.01472113106217355\ \(0\)\
\-\ other\\:\\ 0\\.014482636387518004\ \(0\)\
\-\ this\\:\\ 0\\.014134370784031368\ \(0\)\
\-\ \\'s\\:\\ 0\\.013853283958581214\ \(0\)\
\-\ patient\\:\\ 0\\.012596940160535117\ \(0\)\
\-\ is\\:\\ 0\\.012403473052604242\ \(0\)\
\-\ male\\:\\ 0\\.011361805425643185\ \(0\)\
\-\ disease\\:\\ 0\\.010270128979527237\ \(0\)\
\-\ \\,\\:\\ 0\\.009952575938135566\ \(0\)\
\-\ or\\:\\ 0\\.007364137860027261\ \(0\)\
\-\ a\\:\\ 0\\.0058323500267441365\ \(0\)\
\-\ \\(\\:\\ 0\\.005311483281204857\ \(0\)\
\-\ \\)\\:\\ 0\\.005246600677303714\ \(0\)\
\-\ and\\:\\ 0\\.003970786891151878\ \(0\)\
\-\ with\\:\\ 0\\.0025809744725710975\ \(0\)\
\-\ \\.\\:\\ 0\\.0015661560042946887\ \(0\)\
\-\ of\\:\\ 0\\.0008566455941028561\ \(0\)\
